Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 13/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL812880 | 0.93 | RAPGEF4 (0.50) | RAPGEF4LMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL814620 | 0.91 | RAPGEF4 (0.48) | RAPGEF4LMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL816160 | 0.91 | RAPGEF4 (0.48) | RAPGEF4LMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL814154 | 0.91 | RAPGEF4 (0.48) | RAPGEF4LMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL813197 | 0.91 | RAPGEF4 (0.48) | RAPGEF4LMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL1812889 | 0.91 | RAPGEF4 (0.48) | RAPGEF4LMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL814425 | 0.91 | RAPGEF4 (0.48) | RAPGEF4LMNAALDH1A1MAPTCYP1A2 | |
| SCHEMBL5845349 | 0.90 | RAPGEF4 (0.52) | RAPGEF4LMNAALDH1A1MAPTFFAR4 | |
| Hydrochloric Acid SCHEMBL814581 | 0.89 | RAPGEF4 (0.46) | RAPGEF4LMNAALDH1A1MAPTGAA | |
| Hydrochloric Acid SCHEMBL812732 | 0.89 | RAPGEF4 (0.46) | RAPGEF4LMNAALDH1A1MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117742099-A | Electrostatic latent image developer, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742103-A | Silica particles, toner, developer, cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742104-A | Silica particles, toner, developer, cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742098-A | Toner for developing electrostatic latent image, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742100-A | Toner for developing electrostatic latent image, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742105-A | Electrostatic latent image developer, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742097-A | Toner for developing electrostatic latent image, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742102-A | Silica particles, toner, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117742096-A | Toner for developing electrostatic latent image, electrostatic latent image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | 富士胶片商业创新有限公司 | 2024-03-22 | — | — | CN | disclosed |
| EP-4310148-A1 | COMPOSITE MATERIAL COMPRISING A ROMP-DERIVED POLYOLEFIN EMBEDDED IN A SILICONE MATRIX | Demeta (FR) | 2024-01-24 | — | — | EP | disclosed |
| EP-1395616-A4 | GROUP 8 TRANSITION METAL CARBENE COMPLEXES AS ENANTIOSELECTIVE OLEFIN METATHESIS CATALYSTS | CALIFORNIA INST OF TECHN (US) | 2006-11-22 | — | — | EP | disclosed |
| US-6992034-B2 | Catalyst component for olefin polymerization | FORMOSA PLASTICS CORPORATION, U.S.A. (US) | 2006-01-31 | — | — | US | disclosed |
| EP-1372844-A4 | HIGH ACTIVITY METAL CARBENE METATHESIS CATALYSTS GENERATED USING A THERMALLY ACTIVATED N-HETEROCYCLIC CARBENE PRECURSOR | CALIFORNIA INST OF TECHN (US) | 2005-10-12 | — | — | EP | disclosed |
| US-20050009690-A1 | Catalyst component for olefin polymerization | FORMOSA PLASTICS CORPORATIONS, U.S.A. | 2005-01-13 | — | — | US | disclosed |
| EP-1395616-A2 | GROUP 8 TRANSITION METAL CARBENE COMPLEXES AS ENANTIOSELECTIVE OLEFIN METATHESIS CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2004-03-10 | — | — | EP | disclosed |
| EP-1372844-A1 | HIGH ACTIVITY METAL CARBENE METATHESIS CATALYSTS GENERATED USING A THERMALLY ACTIVATED N-HETEROCYCLIC CARBENE PRECURSOR | California Institute of Technology (US) | 2004-01-02 | — | — | EP | disclosed |
| WO-2003097562-A2 | HIGH ACTIVITY METAL CARBENE METATHESIS CATALYSTS GENERATED USING A THERMALLY ACTIVATED N-HETEROCYCLIC CARBENE PRECURSOR | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-11-27 | — | — | WO | disclosed |
| US-20030055262-A1 | Group 8 transition metal carbene complexes as enantioselective olefin metathesis catalysts | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2003-03-20 | — | — | US | disclosed |
| WO-2002083742-A2 | GROUP 8 TRANSITION METAL CARBENE COMPLEXES AS ENANTIOSELECTIVE OLEFIN METATHESIS CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002076613-A1 | HIGH ACTIVITY METAL CARBENE METATHESIS CATALYSTS GENERATED USING A THERMALLY ACTIVATED N-HETEROCYCLIC CARBENE PRECURSOR | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055262-A1 | Group 8 transition metal carbene complexes as enantioselective olefin metathesis catalysts | ZCCHC8, COG8, CYP2C8 | RAPGEF4 1723/4885LMNA 4582/4885ALDH1A1 1330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.